Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Cancer Research Communications
|
September 23, 2024
Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
Li-Wei Kuo, Lyndsey S Crump, Kathleen O'Neill, et al.
Molecular Cancer Research : MCR
|
August 28, 2016
Cooperative Dynamics of AR and ER Activity in Breast Cancer
Nicholas C D'Amato, Michael A Gordon, Beatrice Babbs, et al.
NPJ Breast Cancer
|
March 18, 2026
Androgen receptor localisation and protein interactions provide insight into steroid mediated metabolic shifts in endocrine resistant breast cancer
Rachel Bleach, Emir Bozkurt, Jingqi Xin, et al.
Cancer Research Communications
|
April 6, 2026
Metastasis-Associated Wound Repair Promotes Reciprocal Lung Epithelium Activation and Breast Cancer Metastatic Outgrowth
Jessica L Christenson, Nicole S Spoelstra, Michelle M Williams, et al.
Cancer Research Communications
|
March 11, 2026
Metastasis-associated wound repair promotes reciprocal lung epithelium activation and breast cancer metastatic outgrowth
Jessica L Christenson, Nicole S Spoelstra, Michelle M Williams, et al.
Cancer Research
|
November 13, 2020
Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of <i>ESR1</i>-Mutant Breast Cancer
Michelle M Williams, Nicole S Spoelstra, Spencer Arnesen, et al.
Communications Biology
|
May 9, 2026
Aggressive breast cancers secrete heme metabolites to alter macrophage immune suppression and function
Michelle M Williams, Jessica L Christenson, Nicole S Spoelstra, et al.
Breast Cancer Research : BCR
|
January 24, 2014
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
Dawn R Cochrane, Sebastián Bernales, Britta M Jacobsen, et al.
NPJ Breast Cancer
|
October 5, 2024
Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2- breast cancer
Anthony D Elias, Alyse W Staley, Monica Fornier, et al.
NPJ Breast Cancer
|
May 20, 2023
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer
Anthony D Elias, Nicole S Spoelstra, Alyse W Staley, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Cancer Research Communications
|
September 23, 2024
Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
Li-Wei Kuo, Lyndsey S Crump, Kathleen O'Neill, et al.
Molecular Cancer Research : MCR
|
August 28, 2016
Cooperative Dynamics of AR and ER Activity in Breast Cancer
Nicholas C D'Amato, Michael A Gordon, Beatrice Babbs, et al.
NPJ Breast Cancer
|
March 18, 2026
Androgen receptor localisation and protein interactions provide insight into steroid mediated metabolic shifts in endocrine resistant breast cancer
Rachel Bleach, Emir Bozkurt, Jingqi Xin, et al.
Cancer Research Communications
|
April 6, 2026
Metastasis-Associated Wound Repair Promotes Reciprocal Lung Epithelium Activation and Breast Cancer Metastatic Outgrowth
Jessica L Christenson, Nicole S Spoelstra, Michelle M Williams, et al.
Cancer Research Communications
|
March 11, 2026
Metastasis-associated wound repair promotes reciprocal lung epithelium activation and breast cancer metastatic outgrowth
Jessica L Christenson, Nicole S Spoelstra, Michelle M Williams, et al.
Cancer Research
|
November 13, 2020
Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of <i>ESR1</i>-Mutant Breast Cancer
Michelle M Williams, Nicole S Spoelstra, Spencer Arnesen, et al.
Communications Biology
|
May 9, 2026
Aggressive breast cancers secrete heme metabolites to alter macrophage immune suppression and function
Michelle M Williams, Jessica L Christenson, Nicole S Spoelstra, et al.
Breast Cancer Research : BCR
|
January 24, 2014
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
Dawn R Cochrane, Sebastián Bernales, Britta M Jacobsen, et al.
NPJ Breast Cancer
|
October 5, 2024
Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2- breast cancer
Anthony D Elias, Alyse W Staley, Monica Fornier, et al.
NPJ Breast Cancer
|
May 20, 2023
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer
Anthony D Elias, Nicole S Spoelstra, Alyse W Staley, et al.
Page
of 5